Curofy
Biomarkers Can Help Guide Immune-Suppressing Treatment after Organ Transplantation
Recently discovered biomarkers may provide valuable new approaches to monitoring immunosuppressive drug therapy in organ transplant recipients—with the potential for individualized therapy to reduce organ rejection and minimize side effects. Click here to read more.
See this content immediately after install